ABASAGLAR

Brand name authorized in: Austria Cyprus Spain Finland France Ireland Lithuania Netherlands Poland United Kingdom

Active ingredients

The drug ABASAGLAR contains one active pharmaceutical ingredient (API):

1 Insulin glargine
UNII 2ZM8CX04RZ - INSULIN GLARGINE

Insulin glargine is a human insulin analogue designed to have a low solubility at neutral pH. After injection, the acidic solution is neutralised leading to formation of a precipitate from which small amounts of insulin glargine are continuously released.

Read about Insulin glargine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Insulin glargine
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting
Discover more medicines within A10AE04

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 114944012
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 138421, 448060, 451991
FR
Base de données publique des médicaments
Identifier(s): 64332894, 66513085
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 301720, 301724
IE
Health Products Regulatory Authority
Identifier(s): 69486
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1074462, 1074466, 1074467, 1080467, 1080470, 1080471, 1091116, 1091117
NL
Z-Index G-Standaard, PRK
Identifier(s): 121312
PL
Rejestru Produktów Leczniczych
Identifier(s): 100332006